Solara Active Pharma Sciences
SOLARANSE

Solara Active Pharma Sciences

₹543.05-4.35 (0.79%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
537.35
Today’s high
554.45
52 week low
422.00
52 week high
734.40
Open price
538.50
Previous close
547.40
Live volume
1,04,778
Lower circuit
434.45
Upper circuit
651.65

Fundamentals

Market Cap
₹2,613Cr
ROE
-0.12%
P/E Ratio(TTM)
--
EPS(TTM)
-1.55
P/B Ratio
2.08
Dividend Yield
0.00%
Industry P/E
33.73
Book Value
263.26
Debt to Equity
0.55
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹392
+12.32%
Profit (Cr)
₹9.60
+155.08%
-25039.06156.3351.6
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)+41%
3Y CAGR0%
Profit growthValue
1Y (TTM)+557%
3Y CAGR+26%

About

Solara Active Pharma Sciences Limited is a pure-play API manufacturer, offering a wide range of APIs and contract manufacturing services.;
CEO/MD
Poorvank Purohit
Founded in
2017
NSE symbol
SOLARA

Shareholding Pattern

Jun '25
Sep '25
Dec '25
Mar '26
May '26
Promoters
42.00%
Retail And Others
40.25%
Foreign Institutions
13.97%
Other Domestic Institutions
2.62%
Mutual Funds
1.16%
Livesquawk
Solara Active Pharma Q4 EBITDA rose to ₹576M from ₹457M YoY. EBITDA margin declined to 14.9% from 16.6% YoY.
2026
15
May
Quarterly & Annual Result
Release date
6
Feb
Quarterly Result
Release date
2025
5
Nov
Quarterly Result
Release date
25
Jul
Quarterly Result
Release date
Events calendar
View upcoming events in other stocks